{"entity":{"type":"insider","cik":"0001773461","url":"/insider/0001773461","json_url":"/insider/0001773461.json","name":"Silvestro Stephen L","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":10,"n_filings":10,"first":"2021-05-19","last":"2025-10-07","span_basis":"filed_date"},"name_variants":[{"name":"Silvestro Stephen L","source":"filing","n_filings":10,"first_seen":"2021-05-19","last_seen":"2025-10-07"}],"transactions":[{"id":5112560,"accession":"0001628280-25-044543","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001628280-25-044543","line_url":"/filing/0001628280-25-044543#line-2","is_derivative":false,"issuer_cik":"0001448431","issuer_name":"OptimizeRx Corp","issuer_ticker":"OPRX","issuer_name_source":null,"issuer_url":"/issuer/0001448431","owner_cik":"0001773461","owner_name":"Silvestro Stephen L","owner_display_name":"Silvestro Stephen L","owner_url":"/insider/0001773461","role":"Officer (Chief Executive Officer)","role_mark":"O","role_mark_label":"Officer (Chief Executive Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1620.0,"shares_display":"1,620","price_per_share":18.75,"price_display":"18.75","price_state":"stated","total_value":30375.0,"total_display":"30,375.00","total_whole":"30,375","shares_owned_after":188916.0,"shares_owned_after_display":"188,916","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-10-03","filed_date":"2025-10-07","scope":"insider"},{"id":6156988,"accession":"0001213900-22-049032","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-22-049032","line_url":"/filing/0001213900-22-049032#line-1","is_derivative":false,"issuer_cik":"0001448431","issuer_name":"OptimizeRx Corp","issuer_ticker":"OPRX","issuer_name_source":null,"issuer_url":"/issuer/0001448431","owner_cik":"0001773461","owner_name":"Silvestro Stephen L","owner_display_name":"Silvestro Stephen L","owner_url":"/insider/0001773461","role":"Officer (CCO)","role_mark":"O","role_mark_label":"Officer (CCO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CCO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3200.0,"shares_display":"3,200","price_per_share":15.66,"price_display":"15.66","price_state":"stated","total_value":50112.0,"total_display":"50,112.00","total_whole":"50,112","shares_owned_after":3200.0,"shares_owned_after_display":"3,200","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-16","filed_date":"2022-08-17","scope":"insider"},{"id":4796131,"accession":"0001213900-21-066731","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001213900-21-066731","line_url":"/filing/0001213900-21-066731#line-2","is_derivative":false,"issuer_cik":"0001448431","issuer_name":"OptimizeRx Corp","issuer_ticker":"OPRX","issuer_name_source":null,"issuer_url":"/issuer/0001448431","owner_cik":"0001773461","owner_name":"Silvestro Stephen L","owner_display_name":"Silvestro Stephen L","owner_url":"/insider/0001773461","role":"Officer (CHIEF COMMERCIAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF COMMERCIAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF COMMERCIAL OFFICER","security_title":"Common Stock pursuant to 10B5-1 plan","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13241.0,"shares_display":"13,241","price_per_share":54.87,"price_display":"54.87","price_state":"stated","total_value":726533.67,"total_display":"726,533.67","total_whole":"726,534","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-12-17","filed_date":"2021-12-21","scope":"insider"},{"id":4437916,"accession":"0001213900-21-060876","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001213900-21-060876","line_url":"/filing/0001213900-21-060876#line-2","is_derivative":false,"issuer_cik":"0001448431","issuer_name":"OptimizeRx Corp","issuer_ticker":"OPRX","issuer_name_source":null,"issuer_url":"/issuer/0001448431","owner_cik":"0001773461","owner_name":"Silvestro Stephen L","owner_display_name":"Silvestro Stephen L","owner_url":"/insider/0001773461","role":"Officer (CHIEF COMMERCIAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF COMMERCIAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF COMMERCIAL OFFICER","security_title":"Common Stock pursuant to 10B5-1 plan","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13241.0,"shares_display":"13,241","price_per_share":73.98,"price_display":"73.98","price_state":"stated","total_value":979569.18,"total_display":"979,569.18","total_whole":"979,569","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-11-17","filed_date":"2021-11-19","scope":"insider"},{"id":4149440,"accession":"0001213900-21-053526","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001213900-21-053526","line_url":"/filing/0001213900-21-053526#line-2","is_derivative":false,"issuer_cik":"0001448431","issuer_name":"OptimizeRx Corp","issuer_ticker":"OPRX","issuer_name_source":null,"issuer_url":"/issuer/0001448431","owner_cik":"0001773461","owner_name":"Silvestro Stephen L","owner_display_name":"Silvestro Stephen L","owner_url":"/insider/0001773461","role":"Officer (CHIEF COMMERCIAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF COMMERCIAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF COMMERCIAL OFFICER","security_title":"Common Stock pursuant to 10B5-1 plan","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13241.0,"shares_display":"13,241","price_per_share":85.38,"price_display":"85.38","price_state":"stated","total_value":1130516.58,"total_display":"1,130,516.58","total_whole":"1,130,517","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-10-18","filed_date":"2021-10-19","scope":"insider"},{"id":4589579,"accession":"0001213900-21-049127","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001213900-21-049127","line_url":"/filing/0001213900-21-049127#line-2","is_derivative":false,"issuer_cik":"0001448431","issuer_name":"OptimizeRx Corp","issuer_ticker":"OPRX","issuer_name_source":null,"issuer_url":"/issuer/0001448431","owner_cik":"0001773461","owner_name":"Silvestro Stephen L","owner_display_name":"Silvestro Stephen L","owner_url":"/insider/0001773461","role":"Officer (CCO)","role_mark":"O","role_mark_label":"Officer (CCO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CCO","security_title":"Common Stock pursuant to 10B5-1 plan","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13242.0,"shares_display":"13,242","price_per_share":69.79,"price_display":"69.79","price_state":"stated","total_value":924159.18,"total_display":"924,159.18","total_whole":"924,159","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-09-17","filed_date":"2021-09-21","scope":"insider"},{"id":5057724,"accession":"0001213900-21-043903","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001213900-21-043903","line_url":"/filing/0001213900-21-043903#line-2","is_derivative":false,"issuer_cik":"0001448431","issuer_name":"OptimizeRx Corp","issuer_ticker":"OPRX","issuer_name_source":null,"issuer_url":"/issuer/0001448431","owner_cik":"0001773461","owner_name":"Silvestro Stephen L","owner_display_name":"Silvestro Stephen L","owner_url":"/insider/0001773461","role":"Officer (CHIEF COMMERCIAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF COMMERCIAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF COMMERCIAL OFFICER","security_title":"Common Stock pursuant to 10B5-1 plan","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13242.0,"shares_display":"13,242","price_per_share":58.41,"price_display":"58.41","price_state":"stated","total_value":773465.22,"total_display":"773,465.22","total_whole":"773,465","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-08-17","filed_date":"2021-08-19","scope":"insider"},{"id":5438377,"accession":"0001213900-21-037937","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001213900-21-037937","line_url":"/filing/0001213900-21-037937#line-2","is_derivative":false,"issuer_cik":"0001448431","issuer_name":"OptimizeRx Corp","issuer_ticker":"OPRX","issuer_name_source":null,"issuer_url":"/issuer/0001448431","owner_cik":"0001773461","owner_name":"Silvestro Stephen L","owner_display_name":"Silvestro Stephen L","owner_url":"/insider/0001773461","role":"Officer (CHIEF COMMERCIAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF COMMERCIAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF COMMERCIAL OFFICER","security_title":"Common Stock pursuant to 10B5-1 plan","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13242.0,"shares_display":"13,242","price_per_share":50.34,"price_display":"50.34","price_state":"stated","total_value":666602.28,"total_display":"666,602.28","total_whole":"666,602","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-07-20","filed_date":"2021-07-21","scope":"insider"},{"id":4679841,"accession":"0001213900-21-033297","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001213900-21-033297","line_url":"/filing/0001213900-21-033297#line-2","is_derivative":false,"issuer_cik":"0001448431","issuer_name":"OptimizeRx Corp","issuer_ticker":"OPRX","issuer_name_source":null,"issuer_url":"/issuer/0001448431","owner_cik":"0001773461","owner_name":"Silvestro Stephen L","owner_display_name":"Silvestro Stephen L","owner_url":"/insider/0001773461","role":"Officer (CHIEF COMMERCIAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF COMMERCIAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF COMMERCIAL OFFICER","security_title":"Common Stock pursuant to 10B5-1 plan","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13242.0,"shares_display":"13,242","price_per_share":53.44,"price_display":"53.44","price_state":"stated","total_value":707652.48,"total_display":"707,652.48","total_whole":"707,652","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-17","filed_date":"2021-06-21","scope":"insider"},{"id":4189877,"accession":"0001213900-21-027936","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001213900-21-027936","line_url":"/filing/0001213900-21-027936#line-2","is_derivative":false,"issuer_cik":"0001448431","issuer_name":"OptimizeRx Corp","issuer_ticker":"OPRX","issuer_name_source":null,"issuer_url":"/issuer/0001448431","owner_cik":"0001773461","owner_name":"Silvestro Stephen L","owner_display_name":"Silvestro Stephen L","owner_url":"/insider/0001773461","role":"Officer (CHIEF COMMERCIAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF COMMERCIAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF COMMERCIAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13242.0,"shares_display":"13,242","price_per_share":42.72,"price_display":"42.72","price_state":"stated","total_value":565698.24,"total_display":"565,698.24","total_whole":"565,698","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-05-17","filed_date":"2021-05-19","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":10,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":1,"open_market":true},{"code":"S","label":"Open-market sale","n":9,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":10},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001448431","name":"OptimizeRx Corp","url":"/issuer/0001448431","role":"Officer (Chief Executive Officer)","n_filings":10,"first_seen":"2021-05-19","last_seen":"2025-10-07"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001773461","retrieved_at":"2026-08-26T21:40:42+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}